试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-28
Acupuncture for Pain in the Emergency Department
编号:NCT02540512登记状态:入组前撤回企业 / 申办者:Loma Linda University
药物 / 成分:Auricular Acupuncture、Acupuncture、Placebo Acupuncture、hydrocodone / acetaminophen 5mg/325mg
登记的停止原因(原文):No participants enrolled
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-28
A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors
编号:NCT02674555登记状态:入组前撤回企业 / 申办者:Astellas Pharma Global Development, Inc.
药物 / 成分:radio-labeled naquotinib、naquotinib
登记的停止原因(原文):Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-28
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
编号:NCT03091998登记状态:入组前撤回企业 / 申办者:Mayo Clinic
药物 / 成分:CD-NP、Placebo
登记的停止原因(原文):No funding available
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-27
In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma
编号:NCT02489266登记状态:入组前撤回企业 / 申办者:National Cancer Institute (NCI)
药物 / 成分:AKTi-treated TIL、Cyclophosphamide、Fludarabine、Aldesleukin
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-26
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
编号:NCT01260103登记状态:入组前撤回企业 / 申办者:Burzynski Research Institute
药物 / 成分:Temozolomide、ANP Therapy
登记的停止原因(原文):Withdrawn: study halted prematurely, prior to enrollment of first participant
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-26
Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
编号:NCT02457026登记状态:入组前撤回企业 / 申办者:Duke University
药物 / 成分:Aflibercept、Triamcinolone Acetonide、Verteporfin
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-26
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
编号:NCT02563782登记状态:入组前撤回企业 / 申办者:Astellas Institute for Regenerative Medicine
药物 / 成分:Sub-retinal transplantation of MA09-hRPE cells、tacrolimus and mycophenolate mofetil、Placebo tacrolimus and mycophenolate mofetil、Sham Surgery
登记的停止原因(原文):Changes to the study design and the cell line
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-25
The Use of Oral Steroids in the Treatment of Cellulitis
编号:NCT00893048登记状态:入组前撤回企业 / 申办者:Milton S. Hershey Medical Center
药物 / 成分:Prednisone、Placebo Oral Tablet
登记的停止原因(原文):Study never enrolled any subjects before auto-terminated by the internal IRB.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-25
Multi-Drug Analgesia vs. Standard Solution for Anal Surgery
编号:NCT03105674登记状态:入组前撤回企业 / 申办者:Columbia University
药物 / 成分:Multi-drug local anesthetics (Combination)、Standard local anesthetics (Combination)
登记的停止原因(原文):Not yet IRB approved and PI will be leaving institution in September.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2017-07-25
A Study Of Ursolic Acid For Primary Sclerosing Cholangitis
编号:NCT03216876登记状态:入组前撤回企业 / 申办者:University of California, Davis
药物 / 成分:Ursolic acid
登记的停止原因(原文):Lack of feasibility
查看官方原始记录 ↗